1. Home
  2. LND vs TNXP Comparison

LND vs TNXP Comparison

Compare LND & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LND
  • TNXP
  • Stock Information
  • Founded
  • LND 2005
  • TNXP 2007
  • Country
  • LND Brazil
  • TNXP United States
  • Employees
  • LND N/A
  • TNXP N/A
  • Industry
  • LND Farming/Seeds/Milling
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LND Consumer Staples
  • TNXP Health Care
  • Exchange
  • LND Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • LND 375.6M
  • TNXP 335.6M
  • IPO Year
  • LND 2006
  • TNXP N/A
  • Fundamental
  • Price
  • LND $3.97
  • TNXP $26.54
  • Analyst Decision
  • LND
  • TNXP Buy
  • Analyst Count
  • LND 0
  • TNXP 1
  • Target Price
  • LND N/A
  • TNXP $70.00
  • AVG Volume (30 Days)
  • LND 33.1K
  • TNXP 1.9M
  • Earning Date
  • LND 11-05-2025
  • TNXP 08-11-2025
  • Dividend Yield
  • LND 6.23%
  • TNXP N/A
  • EPS Growth
  • LND N/A
  • TNXP N/A
  • EPS
  • LND 0.25
  • TNXP N/A
  • Revenue
  • LND $194,084,753.00
  • TNXP $9,831,000.00
  • Revenue This Year
  • LND $55.76
  • TNXP $21.19
  • Revenue Next Year
  • LND N/A
  • TNXP $722.94
  • P/E Ratio
  • LND $15.18
  • TNXP N/A
  • Revenue Growth
  • LND 3.73
  • TNXP N/A
  • 52 Week Low
  • LND $3.49
  • TNXP $6.76
  • 52 Week High
  • LND $4.97
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • LND 63.88
  • TNXP 32.47
  • Support Level
  • LND $3.90
  • TNXP $34.50
  • Resistance Level
  • LND $3.99
  • TNXP $29.70
  • Average True Range (ATR)
  • LND 0.07
  • TNXP 3.35
  • MACD
  • LND 0.02
  • TNXP -1.55
  • Stochastic Oscillator
  • LND 92.26
  • TNXP 4.29

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: